Saba Capital Management’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Saba Capital Management’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-564,142	Closed	-$5.57M	–	1110
2022 Q3	$5.57M	Hold	564,142	–	–	0.06%	496
2022 Q2	$5.54M	Buy	564,142 +125,000	+28%	+$1.23M	0.06%	492
2022 Q1	$4.29M	Buy	439,142 +63,001	+17%	+$615K	0.06%	464
2021 Q4	$3.69M	Hold	376,141	–	–	0.06%	436
2021 Q3	$3.66M	Hold	376,141	–	–	0.09%	279
2021 Q2	$3.64M	Buy	376,141 +78,900	+27%	+$767K	0.1%	203
2021 Q1	$2.86M	Buy	+297,241	New	+$2.88M	0.09%	176

Saba Capital Management's SHAC Position: Q4 2022 in Review

Saba Capital Management sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 564,142 shares — an estimated $5.57M sold.

Saba Capital Management first reported a position in SHAC in Q1 2021 and held it in 7 quarters. The position peaked at $5.57M in Q3 2022. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

Saba Capital Management reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Saba Capital Management sold 564,142 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $5.57M.
Saba Capital Management first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q1 2021 and held it in 7 quarters.
Saba Capital Management's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $5.57M in Q3 2022.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on Saba Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.